B-CELL NON-HODGKIN LYMPHOMA
Clinical trials for B-CELL NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B-CELL NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for B-CELL NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR-T therapy GI001 enters early human trials for tough lymphoma
Disease control Not yet recruitingThis early-phase study tests a new treatment called GI001, a type of CAR-T cell therapy, in 9 adults with B-cell Non-Hodgkin Lymphoma that has come back or not responded to standard treatments. The main goals are to check if GI001 is safe, find the best dose, and see if it can sh…
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
New Dual-Targeting cell therapy takes aim at Hard-to-Treat blood cancers
Disease control Not yet recruitingThis early-phase study tests a new type of immune cell therapy (CAR T cells) that targets two proteins on cancer cells at once. It is for adults with B-cell non-Hodgkin lymphoma whose cancer has not responded to or has returned after other treatments. The main goal is to find a s…
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Experimental NK cell cocktail aims to outsmart resistant lymphoma
Disease control Not yet recruitingThis early-phase trial tests a new combination of drugs and donor immune cells (NK cells) for adults with B-cell non-Hodgkin lymphoma that has not responded to at least two prior treatments. Participants receive chemotherapy followed by infusions of NK cells, rituximab, tafasitam…
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated Jun 05, 2026 12:07 UTC